1.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(9): t831-t832, oct. 2023. ilus
Article
in English
| IBECS
| ID: ibc-226049
2.
J Eur Acad Dermatol Venereol
; 37(7): e936-e938, 2023 07.
Article
in English
| MEDLINE
| ID: mdl-36913262
Subject(s)
Anti-Infective Agents, Local , Dermatitis, Allergic Contact , Child , Humans , Chlorhexidine , Patch Tests , Allergens
3.
Actas Dermosifiliogr
; 114(9): 831-832, 2023 10.
Article
in English, Spanish
| MEDLINE
| ID: mdl-35963327
Subject(s)
Abnormalities, Multiple , Darier Disease , Humans , Imidazoles/adverse effects , Oximes/adverse effects
4.
Actas Dermosifiliogr
; 107(9): 797-798, 2016 Nov.
Article
in English, Spanish
| MEDLINE
| ID: mdl-27210517
Subject(s)
Father-Child Relations , Gestures , Herpes Simplex/transmission , Acyclovir/therapeutic use , Adult , Antiviral Agents/therapeutic use , Early Diagnosis , Encephalitis, Herpes Simplex/prevention & control , Fathers , Female , Herpes Labialis/transmission , Herpes Simplex/drug therapy , Herpes Simplex/virology , Herpesvirus 1, Human/isolation & purification , Humans , Infant, Newborn , Male
5.
Actas Dermosifiliogr
; 101(4): 372-3, 2010 May.
Article
in Spanish
| MEDLINE
| ID: mdl-20487701
6.
Actas Dermosifiliogr
; 100(6): 522-4, 2009.
Article
in Spanish
| MEDLINE
| ID: mdl-19709565
7.
Actas Dermosifiliogr
; 100(2): 152-4, 2009 Mar.
Article
in Spanish
| MEDLINE
| ID: mdl-19445884
Subject(s)
Molluscum Contagiosum/etiology , Tattooing/adverse effects , Adult , Drug Contamination , Equipment Contamination , Humans , Ink , Male , Molluscum Contagiosum/diagnosis , Needles
8.
Actas Dermosifiliogr
; 99 Suppl 1: 74-81, 2008 Jan.
Article
in Spanish
| MEDLINE
| ID: mdl-18341856
ABSTRACT
Efalizumab (Raptiva) is one of the biological agents approved recently for the treatment of patients with moderate-severe psoriasis who have not responded to conventional treatments. It is a humanized IgG1 monoclonal antibody which, due to its anti-D11 effect, is capable of blocking the endothelial migration and T cell activation on the skin, fundamental processes in the etiopathogeny of psoriasis. We present the experience we have had in our hospital over the last two years with 23 patients who have initiated treatment with efalizumab.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Biological Products/therapeutic use , Dermatologic Agents/therapeutic use , Psoriasis/therapy , Adult , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized , Biological Products/adverse effects , Combined Modality Therapy , Cyclosporine/therapeutic use , Dermatitis, Exfoliative/etiology , Dermatologic Agents/adverse effects , Female , Hospitals, Urban , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , PUVA Therapy , Psoriasis/drug therapy , Retrospective Studies , Thrombocytopenia/etiology , Treatment Outcome
9.
Rev Clin Esp
; 189(2): 94-5, 1991 Jun.
Article
in Spanish
| MEDLINE
| ID: mdl-1784791
Subject(s)
Cold Temperature/adverse effects , Complement C3 Nephritic Factor/analysis , Urticaria/blood , Child , Female , Humans
10.
Rev Clin Esp
; 187(8): 436-7, 1990 Nov.
Article
in Spanish
| MEDLINE
| ID: mdl-2128656
11.
Clin Exp Dermatol
; 15(2): 154-5, 1990 Mar.
Article
in English
| MEDLINE
| ID: mdl-2347110